Expression of Endoplasmic Reticulum Stress Related Genes in Blood Cells of Obese Boys with and without Insulin Resistance

EXPERIMENTAL RESEARCH
Dmytro O. Minchenko, PhD1,2

Palladin Institute of Biochemistry National Academy of Sciences of Ukraine; O.O. Bohomolets National Medical University,Kyiv, Ukraine

*Corresponding author: Prof. Dmytro O. Minchenko, PhD, Palladin Institute of Biochemistry,  Kyiv, Ukraine; e-mail: ominchenko@yahoo.com

Published: March 25, 2015. DOI: 10.21103/Article5(1)_ER1

Abstract: 

Objective: to study the changes in the expression level of the subset of genes, encoding for important cell growth factors and enzymes, which play an important role in the control of cellular growth and apoptosis, in blood cells of obese boys with and without insulin resistance for evaluation of its possible significance in the development of obesity and impaired insulin sensitivity.

Material and Methods: We studied the expression of genes, which are responsible for control of cell growth and survival, in blood cells of obese boys with normal and impaired insulin sensitivity as compared to normal (control) individuals.

Results: It was shown that the expression level of PLAGL, CYR61, ITGA5, and TFPI2 genes is increased, but the GADD45A gene is decreased in blood cells of obese children with normal insulin sensitivity as compared to the control group. Insulin resistance in obese boys leads to the up-regulation of PPP1R15A and PLAGL1 gene expressions as well as to the down-regulation of TFPI2, GADD45A, ALDH1A2, CYR61, and HSPA6 genes in blood cells as compared to obese patients with normal insulin sensitivity.  

Conclusion: Results of this study provide evidence that obesity affects the expression of the subset of genes related to the control of cell growth and survival in blood cells and that impaired insulin sensitivity in obesity is associated with changes in the expression level of PLAGL, CYR61, GADD45A, PPP1R15A, TFPI2, ALDH1A2, and HSPA6 genes, which possibly contributes to the development of obesity and its metabolic complications, including insulin resistance.

Keywords: 
mRNA expression, CYR61, PLAGL, ITGA5, PPP1R15A, GADD45A, TFPI2, blood, obesity, insulin resistance.
References: 
  1. Ozcan U, Cao Q, Yilmaz E, Lee AH, Iwakoshi NN, Ozdelen E, et al. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 2004; 306(5695):457–61.
  2. Bray MS, Young ME. Regulation of fatty acid metabolism by cell autonomous circadian clocks: time to fatten up on information?  J Biol Chem 2011; 286 (14): 11883–9.
  3. Kovac J, Husse J, Oster H. A time to fast, a time to feast: the crosstalk between metabolism and the circadian clock. Mol Cells 2009; 28(2):75–80.
  4. Bray MS, Young ME. The role of cell-specific circadian clocks in metabolism and disease. Obes Rev 2009; 10(Suppl 2):6–13.
  5. Ruderman NB, Carling D, Prentki M, Cacicedo JM. AMPK, insulin resistance, and the metabolic syndrome. J Clin Invest 2013; 123(7):2764–72.
  6. Ando H, Kumazaki M, Motosugi Y, Ushijima K, Maekawa T, Ishikawa E, et al. Impairment of peripheral circadian clocks precedes metabolic abnormalities in ob/ob mice. Endocrinology 2011; 152(4):1347–54.
  7. Duong HA, Robles MS, Knutti D, Weitz CJ. A molecular mechanism for circadian clock negative feedback. Science 2011; 332(6036):1436–9.
  8. Shimba S, Ogawa T, Hitosugi S, Ichihashi Y, Nakadaira Y, Kobayashi M, et al. Deficient of a clock gene, brain and muscle Arnt-like protein-1 (BMAL1), induces dyslipidemia and ectopic fat formation. PLoS One 2011; 6(9):e25231.
  9. Wang S, Kaufman RJ. The impact of the unfolded protein response on human disease. J Cell Biol 2012; 197(7):857–67.
  10. Huang J, Gao K, Lin J, Wang Q. MicroRNA-100 inhibits osteosarcoma cell proliferation by targeting Cyr61. Tumour Biol 2014; 35(2):1095-100.
  11. Long QZ, Zhou M, Liu XG, Du YF, Fan JH, Li X, et al. Interaction of CCN1 with αvβ3 integrin induces P-glycoprotein and confers vinblastine resistance in renal carcinoma cells. Anticancer Drugs 2013; 24(8):810-7.
  12. Vieria Neto L, Wildemberg LE, Colli LM, Kasuki L, Marques NV, Moraes AB, et al. ZAC1 and SSTR2 are downregulated in non-functioning pituitary adenomas but not in somatotropinomas. PLoS ONE 2013; 8(10):e77406.
  13. Caffarel MM, Chattopadhyay A, Araujo AM, Bauer J, Scarpini CG, Coleman N. Tissue transglutaminase mediates the pro-malignant effects of oncostatin M receptor over-expression in cervical squamous cell carcinoma. J Pathol 2013; 231(2):168-79.
  14. Arakawa N, Miyagi E, Nomura A, Morita E, Ino Y, Ohtake N, et al. Secretome-based identification of TFPI2, a novel serum biomarker for detection of ovarian clear cell adenocarcinoma. J Proteome Res 2013; 12(10):4340-50.
  15. Hoffman B, Liebermann DA. Gadd45 in modulation of solid tumors and leukemia. Adv Exp Med Biol 2013; 793:21-33.
  16. Zhou W, Jeyaraman K, Yusoff P, Shenolikar S. Phosphorylation at tyrosine 262 promotes GADD34 protein turnover. J Biol Chem 2013; 288(46):33146-55.
  17. Kim H, Lapointe J, Kaygusuz G, Ong DE, Li C, van de Rijn M, et al. The retinoic acid synthesis gene ALDH1a2 is a candidate tumor suppressor in prostate cancer. Cancer Res 2005; 65(18):8118-24.
  18. Lin J, Huo R, Xiao L, Zhu X, Xie J, Sun S, et al. A novel p53/microRNA-22/Cyr61 axis in synovial cells regulates inflammation in rheumatoid arthritis. Arthritis Rheumatol 2014; 66(1):49-59.
  19. Lee YJ, Lee DM, Lee SH. Production of Cyr61 protein is modulated by extracellular acidification and PI3K/Akt signaling in prostate carcinoma PC-3 cells. Food Chem Toxicol 2013; 58:169-76.
  20. Choi J, Lin A, Shrier E, Lau LF, Grant MB, Chaqour B. Degradome products of the matricellular protein CCN1 as modulators of pathological angiogenesis in the retina. J Biol Chem 2013; 288(32):23075-89.
  21. Du X, Rousseau M, Ounissi-Benkalha H, Marchand L, Jetha A, Paraskevas S, et al. Differential expression pattern of ZAC in developing mouse and human pancreas. J Mol Histol 2011; 42(2):129-36.
  22. Zhou J, Wang J, Li N, Zhang X, Zhou H, Zhang R, et al.  Molecularly genetic analysis of von Hippel-Lindau associated central nervous system hemangioblastoma. Pathol Int 2010; 60(6):452-8.
  23. Walter RB, Laszlo GS, Alonzo TA, Gerbing RB, Levy S, Fitzgibbon MP, et al. Significance of expression of ITGA5 and its splice variants in acute myeloid leukemia: a report from the Children's Oncology Group. Am J Hematol 2013; 88(8):694-702.
  24. Xu C, Wang H, He H, Zheng F, Chen Y, Zhang J, et al. Low expression of TFPI-2 associated with poor survival outcome in patients with breast cancer. BMC Cancer 2013; 13:118.
  25. Takada H, Wakabayashi N, Dohi O, Yasui K, Sakakura C, Mitsufuji S, et al. Tissue factor pathway inhibitor 2 (TFPI2) is frequently silenced by aberrant promoter hypermethylation in gastric cancer. Cancer Genet Cytogenet 2010; 197(1):16-24.
  26. Salvador JM, Brown-Clay JD, Fornace AJ Jr. Gadd45 in stress signaling, cell cycle control, and apoptosis. Adv Exp Med Biol 2013; 793:1-19.
  27. Dalton LE, Clarke HJ, Knight J, Lawson MH, Wason J, Lomas DA, et al. The endoplasmic reticulum stress marker CHOP predicts survival in malignant mesothelioma.   Br J Cancer 2013; 108(6):1340-7.
  28. Gyongyosi A, Szatmari I, Pap A, Dezso B, Pos Z, Szeles L, et al. RDH10, RALDH2, and CRABP2 are required components of PPARγ-directed ATRA synthesis and signaling in human dendritic cells. J Lipid Res 2013; 54(9):2458-74.
  29.  Han S, Lan Q, Park AK, Lee KM, Park SK, Ahn HS, et al. Polymorphisms in innate immunity genes and risk of childhood leukemia. Hum Immunol 2010; 71(7):727-30.
  30. Lee J, Ozcan U. Unfolded protein response signaling and metabolic diseases. J Biol Chem 2014; 289(3):1203–11.
  31. Kryvdiuk I, Bakalets T, Riabovol O, Minchenko D. Expression of GADD34 and gadd45 mRNA in U87 glioma cells: effect of blockade of ERN1 signaling enzyme and glucose deprivation. Visnyk Taras Shevchenko Kyiv National Univ (Biology) 2014; 66 (1): 28-32.
  32. Yuzefovych LV, Musiyenko SI, Wilson GL, Rachek LI. Mitochondrial DNA damage and dysfunction, and oxidative stress are associated with endoplasmic reticulum stress, protein degradation and apoptosis in high fat diet-induced insulin resistance mice. PLoS One 2013; 8(1):e54059.
  33. Minchenko D, Ratushna O, Bashta Y, Herasymenko R, Minchenko O. The expression of TIMP1, TIMP2, VCAN, SPARC, CLEC3B and E2F1 in subcutaneous adipose tissue of obese males and glucose intolerance. CellBio 2013; 2(2):25–33.
  34. Bochkov VN, Philippova M, Oskolkova O, Kadl A, Furnkranz A, Karabeg E, et al. Oxidized phospholipids stimulate angiogenesis via autocrine mechanisms, implicating a novel role for lipid oxidation in the evolution of atherosclerotic lesions. Circ Res 2006; 99(8):900–8.
  35. Smith KJ, Twal WO, Soodavar F, Virella G, Lopes-Virella MF, Hammad SM. Heat shock protein 70B' (HSP70B') expression and release in response to human oxidized low density lipoprotein immune complexes in macrophages. J Biol Chem 2010; 285(21):15985–93.

The fully formatted PDF version is available.       

Download Article

Int J Biomed. 2015; 5(1):24-29. © 2015 International Medical Research and Development Corporation. All rights reserved.